These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 32989939)

  • 1. Optimizing the Dosing Regimens of Tigecycline against Vancomycin-Resistant Enterococci in the Treatment of Intra-abdominal and Skin and Soft Tissue Infections.
    Santimaleeworagun W; Hemapanpairoa J; Changpradub D; Thunyaharn S
    Infect Chemother; 2020 Sep; 52(3):345-351. PubMed ID: 32989939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of Linezolid Dosing Regimens for Treatment of Vancomycin-Resistant Enterococci Infection.
    Santimaleeworagun W; Changpradub D; Hemapanpairoa J; Thunyaharn S
    Infect Chemother; 2021 Sep; 53(3):503-511. PubMed ID: 34405596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing the Dosing Regimens of Daptomycin Based on the Susceptible Dose-Dependent Breakpoint against Vancomycin-Resistant Enterococci Infection.
    Santimaleeworagun W; Changpradub D; Thunyaharn S; Hemapanpairoa J
    Antibiotics (Basel); 2019 Nov; 8(4):. PubMed ID: 31795437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monte Carlo simulation evaluation of tigecycline dosing for bacteria with raised minimum inhibitory concentrations in non-critically ill adults.
    Kispal B; Walker SAN
    Eur J Clin Pharmacol; 2021 Feb; 77(2):197-205. PubMed ID: 32975650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of tigecycline against quinolone-resistant Streptococcus pneumoniae, methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci.
    Garrison MW; Nuemiller JJ
    Int J Antimicrob Agents; 2007 Feb; 29(2):191-6. PubMed ID: 17174074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial activity of mupirocin, daptomycin, linezolid, quinupristin/dalfopristin and tigecycline against vancomycin-resistant enterococci (VRE) from clinical isolates in Korea (1998 and 2005).
    Lee DK; Kim Y; Park KS; Yang JW; Kim K; Ha NJ
    J Biochem Mol Biol; 2007 Nov; 40(6):881-7. PubMed ID: 18047782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monte Carlo simulation analysis of ceftobiprole, dalbavancin, daptomycin, tigecycline, linezolid and vancomycin pharmacodynamics against intensive care unit-isolated methicillin-resistant Staphylococcus aureus.
    Salem AH; Zhanel GG; Ibrahim SA; Noreddin AM
    Clin Exp Pharmacol Physiol; 2014 Jun; 41(6):437-43. PubMed ID: 24341387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Best tigecycline dosing for treatment of infections caused by multidrug-resistant pathogens in critically ill patients with different body weights.
    Ibrahim MM; Abuelmatty AM; Mohamed GH; Nasr MA; Hussein AK; Ebaed MED; Sarhan HA
    Drug Des Devel Ther; 2018; 12():4171-4179. PubMed ID: 30584281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Monte Carlo Simulation of Three Antimicrobials for Empiric Treatment of Adult Bloodstream Infections With Carbapenem-Resistant Enterobacterales in China.
    Zou D; Yao G; Shen C; Ji J; Ying C; Wang P; Liu Z; Wang J; Jin Y; Xiao Y
    Front Microbiol; 2021; 12():738812. PubMed ID: 34899628
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment options for vancomycin-resistant enterococcal infections.
    Linden PK
    Drugs; 2002; 62(3):425-41. PubMed ID: 11827558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy and safety of colistimethate sodium in critical patients: an in vitro study by using of Monte Carlo simulation].
    Pan A; Mei Q; Yang T; Gao X; Lu H; Ye Y; Li J; Liu B
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 May; 29(5):385-389. PubMed ID: 28524024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis based on Monte Carlo simulation: How effective is tigecycline in routine antimicrobial therapy?
    Jin L; Liu X; Ren F; Liu Y; Sun N; Bai H; Jiang K; Wu S; Fan G
    Int J Clin Pharmacol Ther; 2021 Jul; 59(7):496-505. PubMed ID: 33960299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of Monte Carlo simulation to evaluate the efficacy of tigecycline and minocycline for the treatment of pneumonia due to carbapenemase-producing Klebsiella pneumoniae.
    Ni W; Li G; Zhao J; Cui J; Wang R; Gao Z; Liu Y
    Infect Dis (Lond); 2018 Jul; 50(7):507-513. PubMed ID: 29316830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determining optimal dosing regimen of oral administration of dicloxacillin using Monte Carlo simulation.
    Yu W; Ji J; Xiao T; Ying C; Fang J; Shen P; Xiao Y
    Drug Des Devel Ther; 2017; 11():1951-1956. PubMed ID: 28721014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of Monte Carlo simulation to evaluate the development of vancomycin resistance in meticillin-resistant Staphylococcus aureus.
    Mei Q; Ye Y; Zhu YL; Cheng J; Yang HF; Liu YY; Li HR; Li JB
    Int J Antimicrob Agents; 2015 Jun; 45(6):652-6. PubMed ID: 25813394
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Mohanty S; Mahapatra A
    Ann Med Surg (Lond); 2021 Feb; 62():228-230. PubMed ID: 33537135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Intravenous Fosfomycin Disodium Dosing Regimens in Critically Ill Patients for Treatment of Carbapenem-Resistant Enterobacterales Infections Using Monte Carlo Simulation.
    Leelawattanachai P; Wattanavijitkul T; Paiboonvong T; Plongla R; Chatsuwan T; Usayaporn S; Nosoongnoen W; Montakantikul P
    Antibiotics (Basel); 2020 Sep; 9(9):. PubMed ID: 32961833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is Meropenem as a Monotherapy Truly Incompetent for Meropenem-Nonsusceptible Bacterial Strains? A Pharmacokinetic/Pharmacodynamic Modeling With Monte Carlo Simulation.
    Song X; Wu Y; Cao L; Yao D; Long M
    Front Microbiol; 2019; 10():2777. PubMed ID: 31849910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and microbiological efficacy of tigecycline for complicated skin-soft-tissue and intra-abdominal infections in a Turkish university hospital.
    Avkan-Oguz V; Yapar N; Alp-Cavus S; Demir Onder K; Aktas E; Gulay Z; Cakır N
    Int J Clin Pract; 2013 Jun; 67(6):505-11. PubMed ID: 23679904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastrointestinal Colonization with Vancomycin-Resistant Enterococci In Hospitalized and Outpatients.
    Trajkovska-Dokic E; Kaftandzieva A; Stojkovska S; Kuzmanovska A; Panovski N
    Open Access Maced J Med Sci; 2015 Mar; 3(1):7-11. PubMed ID: 27275189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.